Literature DB >> 29155497

Clinical and pathological factors associated with progression of diabetic nephropathy.

Shuang Liang1, Guang-Yan Cai1, Xiang-Mei Chen1.   

Abstract

As an important complication of diabetic mellitus, diabetic kidney disease (DKD) is becoming a major cause of morbidity and mortality worldwide. Given the diminished quality of life and the economic cost, identification of the risk factors for DKD and initiation of in-time therapies are of great importance. The initiators of DKD include hyperglycemia and predisposing genes, while the promotors of DKD include hyperglycemia, albuminuria, hypertension, dyslipdemia, insulin resistance, anemia, long duration of diabetes, smoking, ethnicity, westernization, sex, age, and so on. This article summarizes the values and limitations of some factors in the development and progression of DKD. Further study is needed to establish whether modulating these factors can improve the outcomes of DKD.
© 2017 Asian Pacific Society of Nephrology.

Entities:  

Keywords:  diabetic kidney disease; factors; progression

Mesh:

Substances:

Year:  2017        PMID: 29155497     DOI: 10.1111/nep.13182

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  16 in total

Review 1.  The protective effects of SGLT-2 inhibitors, GLP-1 receptor agonists, and RAAS blockers against renal injury in patients with type 2 diabetes.

Authors:  Zengguang Kuang; Ningning Hou; Chengxia Kan; Fang Han; Hongyan Qiu; Xiaodong Sun
Journal:  Int Urol Nephrol       Date:  2022-08-29       Impact factor: 2.266

2.  Glabridin, a bioactive component of licorice, ameliorates diabetic nephropathy by regulating ferroptosis and the VEGF/Akt/ERK pathways.

Authors:  Hongtao Tan; Junxian Chen; Yicong Li; Yingshan Li; Yunchang Zhong; Guangzhao Li; Lingling Liu; Yiqun Li
Journal:  Mol Med       Date:  2022-05-20       Impact factor: 6.376

3.  Risk stratification for children with a solitary functioning kidney.

Authors:  Sander Groen In't Woud; Loes F M van der Zanden; Michiel F Schreuder
Journal:  Pediatr Nephrol       Date:  2021-11       Impact factor: 3.714

4.  High FIB4 index is an independent risk factor of diabetic kidney disease in type 2 diabetes.

Authors:  Haruka Saito; Hayato Tanabe; Akihiro Kudo; Noritaka Machii; Moritake Higa; Satoshi Yamaguchi; Gulinu Maimaituxun; Kazumichi Abe; Atsushi Takahashi; Kenichi Tanaka; Koichi Asahi; Hiroaki Masuzaki; Hiromasa Ohira; Junichiro J Kazama; Michio Shimabukuro
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

5.  Correlation between the levels of serum cystatin C and substance P in peripheral blood in diabetes mellitus patients complicated with hypertension.

Authors:  Wei Zhu; Xuelian Gong; Chao Luo; Jing Lu
Journal:  Exp Ther Med       Date:  2018-06-11       Impact factor: 2.447

6.  Burden of Undiagnosed Type 2 Diabetes in Diabetic Kidney Disease: A Japanese Retrospective Cohort Study.

Authors:  Hayato Tanabe; Haruka Saito; Noritaka Machii; Akihiro Kudo; Kenichi Tanaka; Koichi Asahi; Junichiro James Kazama; Michio Shimabukuro
Journal:  J Clin Med       Date:  2020-06-28       Impact factor: 4.241

7.  Associations between Triglyceride-Glucose Index and Micro- and Macro-angiopathies in Type 2 Diabetes Mellitus.

Authors:  Hsuan Chiu; Hui-Ju Tsai; Jiun-Chi Huang; Pei-Yu Wu; Wei-Hao Hsu; Mei-Yueh Lee; Szu-Chia Chen
Journal:  Nutrients       Date:  2020-01-26       Impact factor: 5.717

8.  The triglyceride glucose index can predict newly diagnosed biopsy-proven diabetic nephropathy in type 2 diabetes: A nested case control study.

Authors:  Jin Shang; Dahai Yu; Yamei Cai; Zheng Wang; Bin Zhao; Zhanzheng Zhao; David Simmons
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

9.  Association between triglyceride glucose index and abnormal liver function in both urban and rural Chinese adult populations: Findings from two independent surveys.

Authors:  Lanfang Yu; Yamei Cai; Rui Qin; Bin Zhao; Xiaona Li
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

10.  Qizhijiangtang capsule for the treatment of diabetic kidney disease: A protocol for systematic review and meta-analysis.

Authors:  Yumeng Tan; Jun Hu; Yueying Zhang; Qian Wu; Qing Ni
Journal:  Medicine (Baltimore)       Date:  2020-08-21       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.